Helminth egg derivatives as proregenerative immunotherapies

Authors:
Open Access
Publisher website
Google Scholar
Abstract
The immune system is increasingly recognized as an important regulator of tissue repair. We developed a regenerative immunotherapy from the helminth Schistosoma mansoni soluble egg antigen (SEA) to stimulate production of interleukin (IL)-4 and other type 2-associated cytokines without negative infection-related sequelae. The regenerative SEA (rSEA) applied to a murine muscle injury induced accumulation of IL-4-expressing T helper cells, eosinophils, and regulatory T cells and decreased expression of IL-17A in gamma delta (γδ) T cells, resulting in improved repair and decreased fibrosis. Encapsulation and controlled release of rSEA in a hydrogel further enhanced type 2 immunity and larger volumes of tissue repair. The broad regenerative capacity of rSEA was validated in articular joint and corneal injury models. These results introduce a regenerative immunotherapy approach using natural helminth derivatives.
Funding Information
  • HHS | National Institutes of Health (DP1AR076959)
  • U.S. Department of War (W81XWH-19-1-0576)
  • HHS | NIH | National Eye Institute (R01EY029055)

This publication has 64 references indexed in Scilit: